Welcome to our dedicated page for Iiot-Oxys SEC filings (Ticker: ITOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Predictive algorithms, sensor gateways, and an early-stage SaaS model make IIOT-OXYS’s filings tougher than most. Whether you are trying to confirm how much the company spends on AI research or need to see if the latest Industry 4.0 contract hit revenue, dissecting a 200-page 10-K is rarely quick.
Stock Titan solves that problem. Our AI reads every IIOT-OXYS annual report 10-K simplified, each IIOT-OXYS quarterly earnings report 10-Q filing, and every IIOT-OXYS 8-K material events explained, then delivers plain-language highlights. Want to monitor IIOT-OXYS insider trading Form 4 transactions? You will receive IIOT-OXYS Form 4 insider transactions real-time the moment they reach EDGAR. The platform also connects the dots between SaaS backlog notes in the MD&A and any IIOT-OXYS proxy statement executive compensation details, showing how leadership incentives align with recurring revenue growth.
Here is what you can do on this page:
- Scan AI-powered summaries for faster IIOT-OXYS earnings report filing analysis
- Track IIOT-OXYS executive stock transactions Form 4 alongside material contract 8-Ks
- Compare R&D outlays quarter over quarter without opening spreadsheets
- Export tables that make understanding IIOT-OXYS SEC documents with AI effortless
From real-time alerts to contextual explanations, every IIOT-OXYS SEC filings explained simply section turns dense disclosures into actionable information—so you can focus on whether those predictive maintenance algorithms are turning into sustainable profit.
IIOT-OXYS, Inc. (ITOX) 10-Q snapshot: The company reported a net loss of $230,724 for the six months ended June 30, 2025 and used $112,726 in operating cash during that period. Management notes an accumulated deficit of $11,438,976 and explicitly states these factors raise substantial doubt about the company’s ability to continue as a going concern. The company remains largely pre-revenue historically, with nominal revenues since 2021.
The balance sheet shows extensive equity and preferred-stock activity: 566,315,293 common shares outstanding at June 30, 2025, multiple series of convertible preferred shares with stated liquidation preferences (Series B approx. $699,600; Series C $68,400; Series D $169,200), and material derivative and mezzanine liabilities related to convertible instruments (derivative liabilities reported at approximately $697,935 at June 30, 2025). Convertible notes and related-party notes carry 12% interest and are secured by substantially all company assets with maturities in early 2026.